Elevance Health (ELV)
Operator of Anthem and Wellpoint health plans plus Carelon pharmacy and care services.
$400.14
vs last close−2.29 (−0.57%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42,849 | 42,647 | 42,577 | 43,646 | 45,145 | 45,442 | 48,891 | 49,776 | 50,711 | 49,747 | 50,181 | 50,474 |
| Cost of revenue | 30,606 | 31,334 | 30,546 | 30,572 | 32,949 | 33,500 | 35,312 | 36,706 | 38,140 | 38,065 | 41,078 | 5,492 |
| Gross profit | 12,243 | 11,313 | 12,031 | 13,074 | 12,196 | 11,942 | 13,579 | 13,070 | 12,571 | 11,682 | 9,103 | 44,982 |
| 10,330 | 10,053 | 8,827 | 10,048 | 10,484 | 10,996 | 10,438 | 10,437 | 10,814 | 11,101 | 6,442 | 42,919 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,330 | 0 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,330 | 0 |
| Other expenses | 10,330 | 10,053 | 8,827 | 10,048 | 10,484 | 10,996 | 10,438 | 10,437 | 10,814 | 11,101 | 112 | 42,919 |
| Operating income | 1,913 | 1,260 | 3,204 | 3,026 | 1,712 | 946 | 3,141 | 2,633 | 1,757 | 581 | 2,661 | 2,063 |
| −259 | −259 | −265 | −40 | −339 | −340 | −344 | −341 | −351 | −366 | −357 | −126 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 704 |
| Interest expense | 259 | 259 | 265 | 280 | 300 | 340 | 344 | 341 | 351 | 366 | 357 | 56 |
| Other non-operating income | 0 | 0 | 0 | −240 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 70 |
| Income before tax | 1,654 | 1,001 | 2,939 | 2,986 | 1,373 | 606 | 2,797 | 2,292 | 1,406 | 215 | 2,304 | 1,937 |
| Income tax expense | 354 | 170 | 690 | 685 | 365 | 193 | 613 | 548 | 219 | −331 | 544 | 483 |
| Net income from continuing operations | 1,300 | 831 | 2,249 | 2,301 | 1,008 | 413 | 2,184 | 1,744 | 1,187 | 546 | 1,760 | 1,454 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 |
| Net income | 1,289 | 856 | 2,246 | 2,300 | 1,016 | 418 | 2,183 | 1,743 | 1,189 | 547 | 1,764 | 1,463 |
| EPS, basic | $5.48 | $3.67 | $9.65 | $9.91 | $4.36 | $1.84 | $9.64 | $7.72 | $5.32 | $2.47 | $8.00 | $6.71 |
| EPS, diluted | $5.45 | $3.63 | $9.59 | $9.85 | $4.36 | $1.81 | $9.61 | $7.72 | $5.32 | $2.47 | $8.00 | $6.71 |
| Weighted average shares, basic | 235 | 233 | 233 | 232 | 233 | 227 | 226 | 226 | 226 | 222 | 220 | 218 |
| Weighted average shares, diluted | 237 | 236 | 234 | 233 | 233 | 231 | 227 | 226 | 226 | 222 | 220 | 218 |
| EBITDA | 2,339 | 1,684 | 3,535 | 3,601 | 2,002 | 1,344 | 3,514 | 3,013 | 2,144 | 987 | 2,773 | 2,103 |
| Depreciation & amortization | 426 | 424 | 331 | 335 | 329 | 398 | 373 | 380 | 387 | 406 | 112 | 110 |
| EBIT | 1,913 | 1,260 | 3,204 | 3,266 | 1,673 | 946 | 3,141 | 2,633 | 1,757 | 581 | 2,661 | 1,993 |
